Press coverage about RTI Surgical (NASDAQ:RTIX) has trended somewhat positive recently, according to Accern Sentiment. The research firm ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. RTI Surgical earned a news sentiment score of 0.13 on Accern’s scale. Accern also assigned news headlines about the medical equipment provider an impact score of 46.1843196454722 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
These are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:
- Comparing RTI Surgical (RTIX) & Amedica (AMDA) (americanbankingnews.com)
- Brokerages Expect RTI Surgical Inc (RTIX) Will Announce Earnings of $0.04 Per Share (americanbankingnews.com)
- RTI Surgical (RTIX) to Acquire Zyga, Improve Spine Surgeries – Nasdaq (nasdaq.com)
- Venture capital-backed Zyga Technology sold to Florida firm (finance.yahoo.com)
A number of equities research analysts recently weighed in on RTIX shares. BidaskClub upgraded shares of RTI Surgical from a “strong sell” rating to a “sell” rating in a research note on Saturday, January 6th. Zacks Investment Research cut shares of RTI Surgical from a “hold” rating to a “sell” rating in a research report on Thursday, October 5th.
RTI Surgical (NASDAQ:RTIX) last released its earnings results on Thursday, November 2nd. The medical equipment provider reported $0.01 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.01. The company had revenue of $66.69 million for the quarter, compared to analysts’ expectations of $65.63 million. RTI Surgical had a return on equity of 2.29% and a net margin of 1.01%. The business’s revenue for the quarter was up .2% on a year-over-year basis. equities analysts anticipate that RTI Surgical will post 0.05 EPS for the current year.
TRADEMARK VIOLATION WARNING: “RTI Surgical (RTIX) Given Daily News Impact Rating of 0.13” was first published by BBNS and is the property of of BBNS. If you are accessing this article on another domain, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The correct version of this article can be read at https://baseballnewssource.com/markets/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-rti-surgical-rtix-stock-price/1817902.html.
About RTI Surgical
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.